Lv41
598 积分 2023-10-07 加入
Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression
12小时前
已完结
Preclinical and Clinical Drug-metabolism, Pharmacokinetics and Safety of Therapeutic Oligonucleotides
2个月前
已完结
Effects of Gastric Acid Suppression, Cytochrome P4503A Inhibition and Induction, and Food on the Pharmacokinetics of Tinlarebant in Healthy Adults
2个月前
已完结
THREE-YEAR CLINICAL OUTCOMES IN GEOGRAPHIC ATROPHY
2个月前
已关闭
Retinotomies and retinectomies: A review of indications, techniques, results, and complications
3个月前
已完结
Rational optimization of siRNA to ensure strand bias in the interaction with the RNA-induced silencing complex
4个月前
已完结
Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota
4个月前
已完结
Multiomic profiling reveals that prostaglandin E2 reverses aged muscle stem cell dysfunction, leading to increased regeneration and strength
7个月前
已完结
Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR
8个月前
已完结
SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study
11个月前
已关闭
皖公网安备34019202002308
